BestLife Holdings Adds Leading Age Management Brand, Cenegenics, To Elevate The Experience Of Aging Through Preventative Medicine

By AIT News Desk On May 25, 2022

Carly Stockdale, CEO of BestLife, Raises $12m Joining with Kristy Berry, CEO of Cenegenics, To Create The BestLife Holdings Platform With Plans To Expand The Longevity Platform In 2022

BestLife Holdings, a portfolio of personalized preventative healthcare and age management solutions, announces its formation with a combined equity round of over $50 million. This funding combines the market-leading performance health brand, Cenegenics, with over $12 million in growth capital. With Cenegenics as the inaugural offering in the portfolio, BestLife is building a multi-brand platform that enables healthy aging at scale.

Latest Aithority Insights: Komodo Health Platform Accelerates Real-World Evidence For Life Sciences

“Over the past 25 years, Cenegenics has established an incredibly effective health performance platform with a 20 location national footprint and extensive telemedicine infrastructure”

“Over the past 25 years, Cenegenics has established an incredibly effective health performance platform with a 20 location national footprint and extensive telemedicine infrastructure,” said Carly Stockdale, CEO of BestLife. “Founders Dr. Alan Mintz and John Adams, along with the early Cenegenics physicians and coaches, pioneered the precision medicine for preventive care field by tracking hundreds of annual biomarkers for clients. They used important but often overlooked clinical data points to educate and deliver impactful, personalized interventions like hormone therapy or supplementation that impact the metabolic, cognitive and physical health of thousands of clients. We are thrilled to invest further in its growth as well as the accompanying scientific insights and digital experience inherent to the program.”

Notable investors have partnered with BestLife including PrimeTime Partners’ founders, Abby Levy, the co-founder of Thrive Global with Arianna Huffington, and Alan Patricof, founder of Greycroft Partners and Apax Partners, who also joined the board as an observer. Consumer and digital health entrepreneurs Neil Parikh, co-founder of Casper, as well as Mitch Rothschild, founder of Vitals, have joined the roster of investors along with professional sports players, including NFL players Peter Kalambayi and Brennan Scarlett.

“Most people seek to live a long and healthy life and yet in 2021, only 5.6% of the total healthcare spend was allocated on preventative medicine. It is clear that our system is built to treat sick people rather than keeping people healthy as they age,” states Alan Patricof. “By circumventing chronic disease before it starts through physician-led age-management protocols, we will be able to change the fundamental basis of healthcare as we know it and rewrite a more positive narrative around the experience of aging.”

Browse The Complete News About Aithority : Clearlake Capital-Backed Cornerstone Completes Acquisition of EdCast

BestLife is committed to furthering the field of age management medicine and performance health. “While lifespan dictates how long a person will live, healthspan describes the length of time a person is healthy,” explains Kristy Berry, Cenegenics CEO, “we are excited to share a first-of-its-kind longitudinal study that demonstrates the beneficial effects of age management protocols on biological age in partnership with leading epigenetics and clinical researchers.” BestLife plans to announce its expanded scientific and medical advisory board later this year while also supporting the continuation of specialized medical education with The Foundation for Healthy Aging that has trained over 1,300 clinicians since 2001.

With co-founders Carly Stockdale and Kristy Berry at the helm, BestLife’s female-led executive team is committed to making precision preventative care available to all with the launch of new age management products. Since joining BestLife, Cenegenics has increased its new client revenues over 120%. The company plans to further invest in growth and product development, making the platform available to executive groups, affiliate physicians, and external partners through expanded partnerships and benefits programs.

[To share your insights with us, please write to sghosh@martechseries.com]